360 High-Risk Vulnerability Immunization Tool V2.0 vs AhnLab AhnLab EPP: Side-by-Side Comparison (2026)

360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..

AhnLab AhnLab EPP: Unified endpoint security platform integrating anti-malware, EDR, and mgmt tools. built by AhnLab. Core capabilities include Unified console for managing multiple endpoint security controls, Single agent architecture for all integrated security tools, Centralized rule and policy enforcement across security controls..

Both serve the Endpoint Protection Platform market but differ in approach, feature depth, and target audience.

360 High-Risk Vulnerability Immunization Tool V2.0 differentiates with Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation. AhnLab AhnLab EPP differentiates with Unified console for managing multiple endpoint security controls, Single agent architecture for all integrated security tools, Centralized rule and policy enforcement across security controls.

360 High-Risk Vulnerability Immunization Tool V2.0 is developed by 360 Security Group (Qihoo 360). AhnLab AhnLab EPP is developed by AhnLab. Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.

360 High-Risk Vulnerability Immunization Tool V2.0 and AhnLab AhnLab EPP serve similar Endpoint Protection Platform use cases: both are Endpoint Protection Platform tools, both cover Patch Management. Review the feature comparison above to determine which fits your requirements.